Law360, New York (August 09, 2012, 4:28 PM ET) -- AmerisourceBergen Corp. on Thursday said it had been subpoenaed by the U.S. Drug Enforcement Administration and the U.S. attorney in New Jersey over potentially illegitimate diversion of controlled substances, the latest sign of law enforcement's stepped-up focus on prescription-drug abuse.
The disclosure, which came in a regulatory filing, says the U.S. attorney’s request for documents was received in connection with a grand jury proceeding and seeks information on the company’s “program for controlling and monitoring diversion of controlled substances into channels other than for legitimate medical,...
AmerisourceBergen Subpoenaed By DEA Over Drug Diversion
To view the full article, take a free trial now.
